Telehealth Advertising: What Health Marketers Must Get Right
What telehealth companies and pharma partners must get right in advertising: drug promotion rules, FTC claims, platform policies, and privacy.
The short answer
Telehealth advertising must follow several sets of rules at once: FDA rules when ads promote prescription drugs, FTC rules on truthful claims and endorsements, platform health ad policies, state medical practice and pharmacy laws, and health privacy laws for any data used in targeting or tracking. Regulators have increased scrutiny of telehealth ads that promote medicines without balanced risk information or that imply a prescription is guaranteed.
Telehealth advertising grew fast, often with consumer-style creative: bold promises, simple sign-up, a medicine shown as the end of the journey. Regulators have noticed. Telehealth companies and the pharma brands that partner with them need to get several rules right at once.
The rule sets
| Area | What it covers |
|---|---|
| FDA drug promotion | Ads that promote specific prescription drugs: balance, risk information, label consistency |
| FTC | Truthful, substantiated claims; endorsements and testimonials; health data practices |
| Platform policies | Google, Meta, and others restrict health ads and require certification for some categories |
| State law | Medical practice, prescribing, and pharmacy rules vary by state |
| Privacy | HIPAA where applicable, FTC rules, state consumer health data laws |
Recent regulatory attention
In September 2025, FDA announced a broad crackdown on misleading drug advertising and said it would look closely at telehealth-related promotion, alongside an HHS fact sheet on the actions. Rules and enforcement continue to evolve, so check current FDA and FTC guidance before launching campaigns.
Claims to avoid
- Implying a prescription is guaranteed.
- Promoting a drug's benefits without balanced risk information.
- Weight loss, hair, or sexual health claims without substantiation.
- Testimonials suggesting atypical results without clear qualification.
- Price claims that hide subscription terms.
Privacy and tracking
The FTC has taken action against health services that shared sensitive data with advertising platforms. For telehealth marketing:
- Review every pixel and tag on sign-up and intake pages.
- Do not send health information to ad platforms without valid consent.
- Check state laws, such as Washington's My Health My Data Act.
See tracking pixel governance and the FTC Health Breach Notification Rule.
Telehealth on CTV
CTV is attractive for telehealth because it combines reach with lower costs than linear TV. Considerations:
- Risk information presentation in video if a drug is promoted.
- Household audiences: ads may reach people for whom the service is not appropriate.
- Targeting with health-related data requires privacy review.
For pharma brands partnering with telehealth
- Review how the platform presents your drug.
- Agree who is responsible for promotional compliance.
- Clarify data flows and any data the brand receives.
- Avoid arrangements that could be seen as paying for prescriptions.
Common mistakes
- Consumer-style performance creative applied to prescription drugs.
- Ad platform pixels firing on intake forms.
- No review of partner platform content.
- Assuming HIPAA is the only privacy law that matters.
Practical takeaway
Before scaling any telehealth campaign, run two reviews together: a promotional review of every ad and landing page that names a drug, and a privacy review of every tag on the sign-up path. Most recent enforcement themes fall into one of those two areas.
Frequently asked questions
Do FDA drug ad rules apply to telehealth companies?
When a telehealth ad promotes a specific prescription drug, regulators may treat it as drug promotion. FDA has signaled closer attention to telehealth-related drug promotion.
Can telehealth ads promise a prescription?
Ads should not imply that a prescription is guaranteed. Prescribing decisions belong to licensed clinicians after evaluation.
What privacy rules apply to telehealth marketing?
Depending on the company, HIPAA, the FTC Act and Health Breach Notification Rule, and state health privacy laws may apply to data used in marketing and tracking.
Sources
- FDA, FDA Launches Crackdown on Deceptive Drug Advertising (September 9, 2025)
- FTC, Health Products Compliance Guidance
- FTC, FTC Gives Final Approval to Order Banning BetterHelp from Sharing Sensitive Health Data for Advertising
- Google Ads policy, Healthcare and medicines
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.